Early NCPAP Before Surfactant Treatment in Very Preterm Infants With RDS

NCT01996670 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 683

Last updated 2013-11-27

No results posted yet for this study

Summary

We hypothesis a period of early NCPAP before surfactant treatment is effective for treating RDS and preventing BPD in very premature infants.

Conditions

  • Nasal Continuous Positive Airway Pressure,
  • Preterm Infants,
  • Surfactant Treatment,
  • Respiratory Distress Syndrome,
  • Bronchopulmonary Dysplasia

Sponsors & Collaborators

  • Xiangya Hospital of Central South University

    lead OTHER

Eligibility

Min Age
30 Minutes
Max Age
2 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2012-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01996670 on ClinicalTrials.gov